<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-4VRTWC9W</identifier><date>2023</date><creator>Boc, Marko</creator><creator>Drobnič, Alja</creator><relation>documents/doc/4/URN_NBN_SI_doc-4VRTWC9W_001.pdf</relation><relation>documents/doc/4/URN_NBN_SI_doc-4VRTWC9W_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 79-81</format><identifier identifier_type="COBISSID_HOST">151894531</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-4VRTWC9W</identifier><language>slv</language><publisher publisher_location="Ljubljana">Katedra za onkologijo</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><publisher publisher_location="Ljubljana">Sekcija za internistično onkologijo</publisher><source>Maligni melanom in ostali kožni raki</source><rights>InC</rights><subject language_type_id="slv">melanom</subject><subject language_type_id="slv">rak kože</subject><subject language_type_id="slv">sistemsko zdravljenje</subject><title>a case report</title><title>Adverse effects in treatment with BRAF and MEK inhibitors</title><title>Neželeni učinki pri zdravljenju z BRAF in MEK zaviralci</title><title>prikaz primera</title></Record>